Lilly boosts immunotherapy pipeline with Armo BioSciences acquisition
Thursday, July 5, 2018 - 18:19
in Mathematics & Economics
The drug company will pay $1.6 billion to gain Armo’s IL-10 program
Updated by artificial intelligence Tue, 13 Jun 2023, 2:53:47 UTC Learn more
- Tell your friends
- Get science news via